First Covers One Of The Early Vioxx Cases, Second Is Legal Thriller Fiction With Parallels To Ketek Fiasco
(Posted by Tom Lamb at DrugInjuryWatch.com)
As the summer reading season draws near, we take a break from our usual reporting to let you know about two new books which provide insights to the world of pharmaceutical drug litigation concerning serious side effects, commonly referred to as drug injury law.
The first new book, which comes out June 7, 2011, is "All the Justice Money Can Buy -- Corporate Greed on Trial", by Snigdha Prakash, an investigative journalist who was a reporter for NPR from 1998 to 2007 where she developed a deep knowledge of the pharmaceutical industry and product liability litigation.
All the Justice Money Can Buy is the true-life story of a courtroom showdown between the man many consider the best trial lawyer of his generation and one of the nation’s richest and most-respected corporations.
Journalist Snigdha Prakash is embedded with the plaintiffs’ team for the seven-week trial, and takes us into the trenches of the tough—and dirty—battle between corporate interests and the individual that plays out in the courts. From early mornings when Lanier works in his hotel suite, to the daily post-mortems after court, and late nights in the plaintiffs’ “war room,” Prakash shadows Lanier and his team.
With its bird’s-eye view of the strategic thinking and meticulous planning that undergird Lanier’s seemingly unrehearsed performances in court, and of the well-oiled machine of lawyers and assistants that backs his every move, All the Justice Money Can Buy is a fast-paced, often funny journey behind the front-lines of a high-stakes, 21st century legal trial. Along the way, Prakash renders a piercing portrait of the challenges that await those who would take on corporate interests.
Part corporate expose´ and part legal thriller, All the Justice Money Can Buy is a gripping—and topical—read for our scandal-plagued times.
The second book, “The Trial”, by Texas attorney Larry D. Thompson, raises serious issues about the pharmaceutical industry's conduct and the FDA’s drug safety oversight. Released in March 2011, this work of fiction will bring to mind the Ketek fiasco, for those familiar with that hard-to-believe real life story.
Here is what the Literary Guild had to say about "The Trial":
A pharmaceutical giant’s disregard for human life spurs to action a small-town lawyer in Larry D. Thompson’s stunning courtroom drama, The Trial. Luke Vaughn’s rage stems from the fact that, unbeknownst to him, his daughter, a rebellious teenager, volunteered for a clinical drug trial that’s left her in desperate need of a liver transplant—and he can’t afford it. So Luke decides to make the culprits pay, and he chooses to do so in the venue he knows best…the courtroom. When Luke discovers what he suspected all along—that the drug company and the FDA knew the pill carried potentially lethal side effects—he thinks the case is won. But his adversary’s prescription for silencing the opposition calls for bribery, kidnapping…and murder.
I thoroughly enjoyed my time with the "The Trial", and I look forward to reading "All The Justice Money Can Buy", soon.
Depending on your preference, fiction or investigative reporting, you will certainly get some insights to the world of drug injury litigation from reading either one of these new books.
DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects
Drug Injury Case Evaluation - Free & Confidential